<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Conditional Neural ODE for Longitudinal Parkinson's Disease Progression Forecasting - Health AI Hub</title>
    <meta name="description" content="This paper introduces CNODE (Conditional Neural ODE), a novel framework designed to forecast the continuous and individualized progression of Parkinson's diseas">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Conditional Neural ODE for Longitudinal Parkinson's Disease Progression Forecasting</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.04789v1" target="_blank">2511.04789v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-06
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Xiaoda Wang, Yuji Zhao, Kaiqiao Han, Xiao Luo, Sanne van Rooij, Jennifer Stevens, Lifang He, Liang Zhan, Yizhou Sun, Wei Wang, Carl Yang
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.04789v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="http://arxiv.org/pdf/2511.04789v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces CNODE (Conditional Neural ODE), a novel framework designed to forecast the continuous and individualized progression of Parkinson's disease (PD). It addresses the limitations of existing methods, such as recurrent neural networks and transformers, which struggle with irregular/sparse MRI data and the inherent patient heterogeneity in PD progression. CNODE leverages neural ordinary differential equations to model brain morphological changes as continuous temporal processes, enhancing individualized forecasting by learning patient-specific initial times and progression speeds.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for advancing personalized medicine in Parkinson's disease by providing a tool to accurately predict individual disease trajectories, which can inform tailored treatment strategies and improve patient management from diagnosis to intervention.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI system (CNODE) is developed to forecast the longitudinal progression of Parkinson's disease by modeling continuous brain morphological changes. This enables the creation of 'individualized digital-twin' forecasts for patients, which can be applied to personalized treatment development, clinical trial stratification, and improved patient monitoring and management.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the challenge of forecasting heterogeneous and evolving brain-morphometry patterns in Parkinson's disease (PD).</li>
                    
                    <li>Proposes CNODE (Conditional Neural ODE) to overcome limitations of existing methods (RNNs, Transformers) with irregular/sparse MRI data and individual patient heterogeneity.</li>
                    
                    <li>Models morphological brain changes as continuous temporal processes using a neural Ordinary Differential Equation (ODE) framework.</li>
                    
                    <li>Incorporates patient-specific personalization by jointly learning individual initial time and progress speed to align trajectories.</li>
                    
                    <li>Validated on the Parkinson's Progression Markers Initiative (PPMI) dataset.</li>
                    
                    <li>Achieves superior performance compared to state-of-the-art baselines in forecasting longitudinal PD progression.</li>
                    
                    <li>Aims to provide mechanistic insight, support treatment development, and enable individualized 'digital-twin' forecasting for PD.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The core methodology involves a Conditional Neural ODE (CNODE) model that treats brain morphological changes as continuous temporal processes. It utilizes a neural ODE to learn the underlying dynamics of disease progression. A key innovation is the joint learning of patient-specific parameters: an individual 'initial time' and a 'progress speed.' These parameters serve to align diverse individual trajectories onto a shared, underlying progression manifold, enabling personalized forecasting despite sparse and irregularly sampled Magnetic Resonance Imaging (MRI) data.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The CNODE framework successfully outperforms state-of-the-art baseline methods in forecasting longitudinal Parkinson's disease progression. This superior performance was demonstrated through validation on the Parkinson's Progression Markers Initiative (PPMI) dataset, indicating its effectiveness in handling the complexities of heterogeneous and irregularly sampled clinical data.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The ability to accurately forecast individual PD progression trajectories has significant clinical impact. It could enable earlier and more precise diagnosis, facilitate the development and testing of new therapies by identifying optimal intervention windows, support personalized treatment planning, and eventually lead to 'digital twin' models for individual patients, allowing clinicians to simulate the effects of different interventions.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations of the proposed method or study. Potential implicit limitations (not mentioned in the abstract) could include generalizability beyond the PPMI dataset, computational cost of Neural ODEs, or specific interpretability challenges of the learned latent dynamics.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract mentions that the work enables mechanistic insight, treatment development, and individualized 'digital-twin' forecasting, implying these as direct applications and potential future avenues. It suggests further research into utilizing the continuous individual trajectories for deeper understanding of PD mechanisms and for creating predictive models that guide clinical decisions and therapeutic interventions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Neurology</span>
                    
                    <span class="tag">Neuroscience</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                    <span class="tag">Computational Medicine</span>
                    
                    <span class="tag">Precision Medicine</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Parkinson's Disease</span>
                    
                    <span class="tag tag-keyword">Neural ODE</span>
                    
                    <span class="tag tag-keyword">Longitudinal Forecasting</span>
                    
                    <span class="tag tag-keyword">MRI</span>
                    
                    <span class="tag tag-keyword">Heterogeneity</span>
                    
                    <span class="tag tag-keyword">Digital Twin</span>
                    
                    <span class="tag tag-keyword">Disease Progression</span>
                    
                    <span class="tag tag-keyword">Machine Learning</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Parkinson's disease (PD) shows heterogeneous, evolving brain-morphometry
patterns. Modeling these longitudinal trajectories enables mechanistic insight,
treatment development, and individualized 'digital-twin' forecasting. However,
existing methods usually adopt recurrent neural networks and transformer
architectures, which rely on discrete, regularly sampled data while struggling
to handle irregular and sparse magnetic resonance imaging (MRI) in PD cohorts.
Moreover, these methods have difficulty capturing individual heterogeneity
including variations in disease onset, progression rate, and symptom severity,
which is a hallmark of PD. To address these challenges, we propose CNODE
(Conditional Neural ODE), a novel framework for continuous, individualized PD
progression forecasting. The core of CNODE is to model morphological brain
changes as continuous temporal processes using a neural ODE model. In addition,
we jointly learn patient-specific initial time and progress speed to align
individual trajectories into a shared progression trajectory. We validate CNODE
on the Parkinson's Progression Markers Initiative (PPMI) dataset. Experimental
results show that our method outperforms state-of-the-art baselines in
forecasting longitudinal PD progression.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted to IEEE International Conference on Bioinformatics and
  Biomedicine (BIBM) 2025</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>